Prostate cancer – genetic predisposition - panel (CHEK2 - 4 mutations, BRCA1, NBS1)
Analysis ID 213
Analysis location “GENESIS” Centre for Medical Genetics
Diagnosed illness Prostate cancer – genetic predisposition - panel (CHEK2 - 4 mutations, BRCA1, NBS1)
OMIM
Clinical information
Type of analysis Molecular
Type of biological material 5 ml of peripheral blood collected in an ETDA tube; DNA sample
Analyzed genes BRCA1; CHEK2; NBS1
Analysis description Analysis consists of a testing for the mutations in CHEK2, BRCA1, and NBS1 genes, which increase the risk of developing prostate cancer
Analysis indication Familial cases of prostate cancer
Analysis time 1 - 2 weeks
Refund No
CGM laboratory name Laboratory for Molecular Genetics and Oncology